The prototypical RAS→RAF→MEK→ERK signaling pathway has been covered in reviews on RAS-ERK biochemistry and hyperactivation in cancer (Roberts and Der, 2007; Mendoza et al., 2011a; Lavoie et al., 2020). This evidence concerns the gene MAPK1 and cancer.